German genetic medicine company ViGeneron has announced a rebrand to become VeonGen Therapeutics. The privately-held firm has ...

US rare disease meds developer Sarepta Therapeutics (Nasdaq: SRPT) revealed that its rAAVrh74 viral vector used in the ...

San Jose, USA-based biotech Allay Therapeutics today announced the completion of a $57.5 million Series D financing round ...

US biopharma Cullinan Therapeutics has entered into an agreement with Genrix Bio for an all-indication, exclusive license to ...

China’s National Medical Products Administration approved its first domestically-developed nine-valent human papillomavirus ...

AI-enabled biotech Juvenescence today announced the acquisition of Ro5 Inc, a proprietary AI drug discovery company. This ...

The atopic dermatitis market across the seven major markets is forecast to nearly triple in value over the next decade, ...

The NHS Business Services Authority (NHSBSA) has published the annual Prescription Cost Analysis (PCA) for 2024/25.

A sweeping legislative package backed by US President Donald Trump could strip health insurance from more than 16 million ...

USA-based subsidiary Vividion Therapeutics has taken over full development and commercialization rights for VVD-214, a ...

Germany’s Formycon has announced that the Brazilian regulatory authority Anvisa has granted marketing authorization for ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to women taking popular medicines ...